SHAREHOLDER INQUIRY: Halper Sadeh LLC investigates ISEE, OPCH,…

SHAREHOLDER INQUIRY: Halper Sadeh LLC investigates ISEE, OPCH,…

Facebook
Twitter
LinkedIn

NEW YORK, May 14, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for possible violations of federal securities laws and/or breaches of fiduciary duties to shareholders related to:

Iveric Bio, Inc. I UNDERSTAND‘S Sold to Astellas Pharma Inc. for $40.00 per share in cash. If you are an Iveric shareholder, Click here to learn more about your rights and options.

Option Care Health, Inc. OPCH‘S Merged with Amedisys, Inc. Upon completion of the Proposed Transaction, Option Care shareholders will own approximately 64.5% of the combined company. If you are an Option Care shareholder, Click here to learn more about your rights and options.

Amedisys, Inc. AMEED‘S Sold to Option Care Health, Inc. for 3,0213 Option Care common shares for each Amedisys common share. If you are an Amedisys shareholder, Click here to learn more about your rights and options.

Shareholders are asked to contact the company for free to discuss your legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors worldwide who have been victims of securities fraud and corporate wrongdoing. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

attorney advertising. Previous results do not guarantee a similar result.

Contact information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com




Source story

More to explorer